Immunotherapy Drugs - Global Market Outlook (2016-2022)

August 2016 | 129 pages | ID: IA601103F0FEN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Immunotherapy Drugs market is accounted for $38.26 billion in 2015 and is expected to reach $97.47 billion by 2022 growing at a CAGR of 14.3%. In present scenario people are exposed to various harmful conditions which are affecting them through cancer and immunotherapy drugs are helping the people out. Rising cancer therapies coupled with lesser side effects are the factors provoking the market demand. Moreover high prevalence of lifestyle diseases are sustaining the market growth. However, high cost of therapy drugs is major factor restraining the market.

Monoclonal antibodies is accounted for largest market share while Checkpoint inhibitors is estimated to be the fastest growing segment on account of its less effect to normal cells compared to ordinary therapeutics. North America commanded the largest market share followed by Europe owing to large government funding in cancer techniques and R&D. Quick drug approvals is also a major factor helping the regional growth.

Some of the key players of the Immunotherapy Drugs market include Aduro BioTech Inc, Agenus Inc, Amgen Inc., Bavarian Nordic A/S, Bellicum Pharmaceuticals Inc, Biogen Idec Inc, Bristol-Myers Squibb Company, Celgene Corporation, DenDrit Biotech USA, ELI Lilly and Company, F. Hoffmann-La Roche Ag, Galena Biopharma Inc, Genentech Inc, Glaxosmithkline Plc, Merck & Co., Inc., NewLink Genetics Corp., Novartis International Ag, Oxford BioTherapeutics Ltd., Seattle Genetics, Inc. and Spectrum Pharmaceuticals, Inc..

Drug Types Covered:

• Checkpoint Inhibitors
• Interferons
• Interleukins
• Monoclonal Antibodies
• Vaccines

Applications Covered:

• Blood Cancer
• Breast Cancer
• Cervical Cancer
• Gastric Cancer
• Glioblastoma
• Lung Cancer
• Melanoma
• Prostate Cancer

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging markets

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL IMMUNOTHERAPY DRUGS, BY TYPE OF DRUGS

5.1 Introduction
5.2 Checkpoint Inhibitors
5.3 Interferons
5.4 Interleukins
5.5 Monoclonal Antibodies
5.6 Vaccines

6 GLOBAL IMMUNOTHERAPY DRUGS, BY APPLICATION

6.1 Introduction
6.2 Blood Cancer
6.3 Breast Cancer
6.4 Cervical Cancer
6.5 Gastric Cancer
6.6 Glioblastoma
6.7 Lung Cancer
6.8 Melanoma
6.9 Prostate Cancer

7 GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY GEOGRAPHY

7.1 North America
  7.1.1 US
  7.1.2 Canada
  7.1.3 Mexico
7.2 Europe
  7.2.1 Germany
  7.2.2 France
  7.2.3 Italy
  7.2.4 UK
  7.2.5 Spain
  7.2.6 Rest of Europe
7.3 Asia Pacific
  7.3.1 Japan
  7.3.2 China
  7.3.3 India
  7.3.4 Australia
  7.3.5 New Zealand
  7.3.6 Rest of Asia Pacific
7.4 Rest of the World
  7.4.1 Middle East
  7.4.2 Brazil
  7.4.3 Argentina
  7.4.4 South Africa
  7.4.5 Egypt

8 KEY DEVELOPMENTS

8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 COMPANY PROFILING

9.1 Aduro BioTech Inc
9.2 Agenus Inc
9.3 Amgen Inc.
9.4 Bavarian Nordic A/S
9.5 Bellicum Pharmaceuticals Inc
9.6 Biogen Idec Inc
9.7 Bristol-Myers Squibb Company
9.8 Celgene Corporation
9.9 DenDrit Biotech USA
9.10 ELI Lilly and Company
9.11 F. Hoffmann-La Roche Ag
9.12 Galena Biopharma Inc
9.13 Genentech Inc
9.14 Glaxosmithkline Plc
9.15 Merck & Co., Inc.
9.16 NewLink Genetics Corp.
9.17 Novartis International Ag
9.18 Oxford BioTherapeutics Ltd.
9.19 Seattle Genetics, Inc.
9.20 Spectrum Pharmaceuticals, Inc.

List Of Tables

LIST OF TABLES

1 Global Immunotherapy Drugs market, By Region (2013-2022) ($MN)
2 Global Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
3 Global Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
4 Global Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
5 Global Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
6 Global Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
7 Global Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
8 Global Immunotherapy Drugs market, By Application (2013-2022) ($MN)
9 Global Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
10 Global Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
11 Global Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
12 Global Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
13 Global Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
14 Global Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
15 Global Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
16 Global Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)
17 North America Immunotherapy Drugs market, By Country (2013-2022) ($MN)
18 North America Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
19 North America Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
20 North America Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
21 North America Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
22 North America Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
23 North America Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
24 North America Immunotherapy Drugs market, By Application (2013-2022) ($MN)
25 North America Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
26 North America Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
27 North America Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
28 North America Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
29 North America Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
30 North America Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
31 North America Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
32 North America Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)
33 Europe Immunotherapy Drugs market, By Country (2013-2022) ($MN)
34 Europe Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
35 Europe Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
36 Europe Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
37 Europe Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
38 Europe Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
39 Europe Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
40 Europe Immunotherapy Drugs market, By Application (2013-2022) ($MN)
41 Europe Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
42 Europe Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
43 Europe Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
44 Europe Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
45 Europe Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
46 Europe Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
47 Europe Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
48 Europe Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)
49 Asia Pacific Immunotherapy Drugs market, By Country (2013-2022) ($MN)
50 Asia Pacific Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
51 Asia Pacific Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
52 Asia Pacific Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
53 Asia Pacific Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
54 Asia Pacific Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
55 Asia Pacific Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
56 Asia Pacific Immunotherapy Drugs market, By Application (2013-2022) ($MN)
57 Asia Pacific Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
58 Asia Pacific Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
59 Asia Pacific Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
60 Asia Pacific Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
61 Asia Pacific Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
62 Asia Pacific Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
63 Asia Pacific Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
64 Asia Pacific Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)
65 RoW Immunotherapy Drugs market, By Country (2013-2022) ($MN)
66 RoW Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
67 RoW Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
68 RoW Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
69 RoW Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
70 RoW Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
71 RoW Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
72 RoW Immunotherapy Drugs market, By Application (2013-2022) ($MN)
73 RoW Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
74 RoW Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
75 RoW Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
76 RoW Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
77 RoW Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
78 RoW Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
79 RoW Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
80 RoW Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)